Profile: Eli Lilly and Co discovers, develops, manufactures & supplies primarily pharmaceutical products in the United States and internationally. Our Alimta® is a chemotherapy regimen approved by the FDA to treat patients with malignant pleural mesothelioma who are not candidates for surgery. Our Forteo® is a medicine for osteoporosis patients that stimulate new bone formation. Our Xigris® is a treatment approved for adult severe-sepsis patients at a high risk of death.